Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-004569
Filing Date
2025-01-17
Accepted
2025-01-17 17:45:25
Documents
1
Period of Report
2025-01-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm253633-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm253633-1_4seq1.xml 4 4894
  Complete submission text file 0001104659-25-004569.txt   6521
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560
Business Address
Ali Asif (Reporting) CIK: 0001921163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 25539784